<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Approach to the child with acute diarrhea in resource-limited settings</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Approach to the child with acute diarrhea in resource-limited settings</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Approach to the child with acute diarrhea in resource-limited settings</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Jason B Harris, MD, MPH</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Mark Pietroni, MA, FRCP, FFPH, DTM&amp;H</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Mohammod Jobayer Chisti, MBBS, MMed, PhD</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Stephen B Calderwood, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Morven S Edwards, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Elinor L Baron, MD, DTMH</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jan 26, 2024.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1159942320"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Diarrhea refers to passage of loose or watery stools at least three times in a 24-hour period [<a href="#rid1">1</a>]. Diarrheal illness is an important cause of child mortality; among children &lt;5 years of age worldwide, it caused over 480,000 estimated deaths in 2019 [<a href="#rid2">2</a>]. </p><p>In resource-limited settings, infants experience a median of six episodes annually, and children experience a median of three episodes annually. There is considerable geographic variability in the incidence and associated mortality of diarrheal illnesses; certain regions may need targeted interventions to improve these outcomes [<a href="#rid3">3,4</a>]. </p><p>In 2005, the World Health Organization (WHO) issued guidelines for the management of diarrheal illness in resource-limited settings in "The Treatment of Diarrhea: A Manual for Physicians and Other Senior Health Workers" [<a href="#rid1">1</a>].</p><p>Issues related to the etiology, clinical assessment, management, and prevention of acute diarrhea in children in resource-limited settings are reviewed here. </p><p>Issues related to persistent diarrhea in children in resource-limited settings are discussed separately. (See  <a class="medical medical_review" href="/d/html/5878.html" rel="external">"Persistent diarrhea in children in resource-limited settings"</a>.) </p><p class="headingAnchor" id="H1159942355"><span class="h1">ETIOLOGY</span><span class="headingEndMark"> — </span>Most cases of acute diarrhea in resource-limited settings are caused by infectious gastroenteritis; patients may present with watery diarrhea or invasive (bloody) diarrhea. Less commonly, acute diarrhea may be a symptom of a systemic infection or an intra-abdominal surgical emergency. </p><p class="headingAnchor" id="H17612372"><span class="h2">Infectious causes</span><span class="headingEndMark"> — </span>Causes of diarrhea differ by age group and geographical region. The microbial etiology of watery diarrhea differs from that of invasive (bloody) diarrhea, as discussed below  (<a class="graphic graphic_table graphicRef50975" href="/d/graphic/50975.html" rel="external">table 1</a>). (See <a class="local">'Watery diarrhea'</a> below and <a class="local">'Invasive (bloody) diarrhea'</a> below.) </p><p>In a 2013 study of children &lt;5 years of age in Asia and Africa, stool samples from 9439 children with moderate to severe diarrhea and 13,129 controls were tested for a panel of microorganisms [<a href="#rid5">5</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Rotavirus, <em>Cryptosporidium</em>, <em>Shigella</em>, and enterotoxigenic <em>Escherichia coli</em> (ETEC) were important pathogens at all study sites, and most attributable cases of diarrhea were due to these organisms. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Rotavirus was the most common pathogen among children &lt;2 years of age, whereas <em>Shigella</em> was the most frequently isolated pathogen in children aged two to five years. <em>Cryptosporidium</em> was the second most common pathogen among infants &lt;1 year of age; it was detected infrequently among children &gt;2 years. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><em>Aeromonas</em> was a frequent pathogen in Pakistan and Bangladesh; <em>Campylobacter jejuni</em> was a frequent pathogen in Pakistan, Bangladesh, and India. <em>Vibrio cholerae</em> was an important cause of diarrhea at those sites as well as in Mozambique. </p><p></p><p>In a follow-up 2016 study that tested a subset of these specimens with a more sensitive panel of molecular tests (quantitative polymerase chain reaction [PCR]), a higher proportion of diarrheal cases were associated with a detectable pathogen (89 versus 52 percent in the earlier study), and adenovirus 40/41 was identified as an additional common pathogen [<a href="#rid6">6</a>]. </p><p>Similar findings were observed in a 2023 study including 6692 children &lt;2 years with diarrhea in Asia and Africa (rotavirus 21 percent, ETEC 13 percent, <em>Shigella</em> 12 percent, and <em>Cryptosporidium</em> 9 percent) [<a href="#rid7">7</a>]. </p><p>Norovirus was not identified as a top cause of diarrhea in this hospital-based study. In a separate community-based cohort including 199 children, norovirus was identified in approximately 25 percent of diarrheal episodes; however, given the prevalence of asymptomatic carriage and copathogens, norovirus was estimated to cause approximately 5 percent of cases [<a href="#rid8">8</a>]. Another systematic review of 130 case-control studies suggested that rotavirus, adenovirus 40/41, and <em>Shigella</em> had the strongest associations with diarrhea among young children [<a href="#rid9">9</a>]. </p><p class="headingAnchor" id="H1159942362"><span class="h3">Watery diarrhea</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Definition</strong> – Watery diarrhea refers to passage of ≥3 stools per day with no visible blood  (<a class="graphic graphic_table graphicRef50975" href="/d/graphic/50975.html" rel="external">table 1</a>). Many etiologic agents of acute watery diarrhea cause symptoms that are clinically indistinguishable. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Etiology</strong> </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Infants and young children</strong> – In infants and young children, watery diarrhea is most often due to rotavirus [<a href="#rid10">10</a>]. <em>Cryptosporidium</em> is also an important cause among infants, even in the absence of human immunodeficiency virus (HIV) infection [<a href="#rid5">5</a>]. (See  <a class="medical medical_review" href="/d/html/2681.html" rel="external">"Clinical manifestations and diagnosis of rotavirus infection", section on 'Clinical manifestations'</a> and  <a class="medical medical_review" href="/d/html/5733.html" rel="external">"Cryptosporidiosis: Epidemiology, clinical manifestations, and diagnosis"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Older children</strong> – In older children, acute watery diarrhea is most often due to ETEC [<a href="#rid11">11</a>]. (See  <a class="medical medical_review" href="/d/html/2720.html" rel="external">"Pathogenic Escherichia coli associated with diarrhea"</a>.)</p><p></p><p class="bulletIndent2">Cholera (due to <em>V. cholerae</em>) is also an important cause of diarrhea in children ≥2 years of age. Cholera should be suspected if a child ≥5 years of age develops severe dehydration from acute watery diarrhea (usually with vomiting) or any patient ≥2 years of age has acute watery diarrhea when cholera is known to be occurring in the area. Children &lt;2 years of age develop cholera rarely; in this group, the illness may be difficult to distinguish from other causes of acute watery diarrhea, especially rotavirus. (See  <a class="medical medical_review" href="/d/html/2704.html" rel="external">"Cholera: Epidemiology, clinical features, and diagnosis"</a>.)</p><p></p><p class="headingAnchor" id="H1159942369"><span class="h3">Invasive (bloody) diarrhea</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Definition</strong> – Invasive (bloody) diarrhea, or dysentery, refers to the passage of ≥3 stools per day mixed with visible blood  (<a class="graphic graphic_table graphicRef50975" href="/d/graphic/50975.html" rel="external">table 1</a>). Bloody diarrhea usually occurs as a result of exudative inflammation of the distal small bowel and colonic mucosa in response to bacterial invasion.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Etiology</strong> </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Shigellosis</strong> – Shigellosis is the most common etiology of invasive diarrhea among children in resource-limited settings. It is a major cause of mortality and is associated with a high incidence of bacteremia, seizures, and several other life-threatening complications. The four species are <em>Shigella dysenteriae</em>, <em>Shigella flexneri</em>, <em>Shigella boydii</em>, and <em>Shigella sonnei</em>. <em>S.</em> <em>flexneri</em> is the predominant species in children in resource-limited settings [<a href="#rid12">12</a>]. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Other etiologies</strong> – Other bacterial etiologies of invasive diarrhea include <em>Salmonella enterica</em>, <em>Campylobacter</em> spp, enterohemorrhagic <em>E. coli</em>, and enteroinvasive <em>E. coli</em>. (See related topics.)</p><p></p><p class="bulletIndent1">The protozoan parasite <em>Entamoeba histolytica</em> is an unusual cause of invasive diarrhea in children (less than 3 percent of episodes) [<a href="#rid1">1</a>]. Amebic dysentery due to <em>E. histolytica</em> may be clinically indistinguishable from shigellosis and does not respond to anti-<em>Shigella</em> therapy. (See  <a class="medical medical_review" href="/d/html/5727.html" rel="external">"Intestinal Entamoeba histolytica amebiasis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hemolytic uremic syndrome (HUS)</strong> – HUS is a rare complication associated with diarrheal illness due to Shiga toxin-producing <em>E. coli</em> (STEC) and <em>S. dysenteriae</em>; it is defined by the triad of microangiopathic hemolytic anemia, thrombocytopenia, and acute kidney injury. (See  <a class="medical medical_review" href="/d/html/89549.html" rel="external">"Overview of hemolytic uremic syndrome in children"</a>.)</p><p></p><p class="headingAnchor" id="H1159942376"><span class="h2">Additional conditions associated with diarrhea</span><span class="headingEndMark"> — </span>Systemic infections that may be associated with diarrhea include influenza, measles, dengue fever, HIV infection, malaria, and sepsis. Extraintestinal bacterial infections that may be associated with diarrhea include pneumonia, urinary tract infection, and meningitis. (See related topics.) </p><p>Intraabdominal processes such as obstruction, intussusception, or appendicitis may present with diarrhea [<a href="#rid13">13-15</a>].</p><p>Milk intolerance is a rare cause of diarrhea in resource-limited settings; this diagnosis should not be applied unless milk refeeding causes a prompt increase in stool volume, weight loss, and worsening of dehydration.</p><p class="headingAnchor" id="H2513793117"><span class="h1">CLINICAL MANIFESTATIONS AND COMPLICATIONS</span></p><p class="headingAnchor" id="H1519352568"><span class="h2">Classification of diarrhea</span><span class="headingEndMark"> — </span>Diarrhea refers to the passage of loose or watery stools at least three times in a 24-hour period [<a href="#rid1">1</a>]. </p><p>Acute diarrhea refers to &lt;14 days of symptoms; it may be further classified as follows:</p><p class="bulletIndent1"><span class="glyph">●</span>Watery diarrhea – Diarrhea with no visible blood  (<a class="graphic graphic_picture graphicRef52564" href="/d/graphic/52564.html" rel="external">picture 1</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Invasive (bloody) diarrhea – Diarrhea with visible blood and/or mucus (by history or inspection)  (<a class="graphic graphic_picture graphicRef64377" href="/d/graphic/64377.html" rel="external">picture 2</a>), commonly accompanied by fever</p><p></p><p>Persistent diarrhea refers to ≥14 days of symptoms. (See  <a class="medical medical_review" href="/d/html/5878.html" rel="external">"Persistent diarrhea in children in resource-limited settings"</a>.) </p><p class="headingAnchor" id="H1361781325"><span class="h2">Dehydration and electrolyte disturbances</span><span class="headingEndMark"> — </span>Dehydration is an important cause of mortality in resource-limited settings; in some cases, this may be attributable to underestimation of the initial hydration status and/or the extent of ongoing fluid loss [<a href="#rid1">1</a>]. </p><p>Electrolyte disturbances may include hypokalemia, hyponatremia, and hypernatremia. (See separate topics.) </p><p>Stool potassium losses commonly result in hypokalemia. This most often manifests with muscle weakness; in more severe cases, hypokalemia may be complicated by paralytic ileus and/or arrhythmia. Among 140 patients who died following rehydration therapy in Bangladesh, hypokalemia was a proximate cause of death in 9 percent of cases [<a href="#rid16">16</a>]. </p><p class="headingAnchor" id="H384455650"><span class="h2">Malnutrition</span><span class="headingEndMark"> — </span>Recurrent diarrhea may be associated with malnutrition, which can contribute to delays in physical and cognitive development; in some cases, deficits are irreversible [<a href="#rid15">15,17-19</a>]. Clinical manifestations of severe malnutrition are described separately  (<a class="graphic graphic_table graphicRef60869" href="/d/graphic/60869.html" rel="external">table 2</a>). (See  <a class="medical medical_review" href="/d/html/5883.html" rel="external">"Malnutrition in children in resource-limited settings: Clinical assessment"</a>.) </p><p>The mortality of children with diarrhea and severe malnutrition may exceed 50 percent [<a href="#rid15">15</a>]. In severely malnourished patients, important clinical signs of dehydration may be masked by kwashiorkor and sepsis.</p><p>In settings where bodily stores of <a class="drug drug_pediatric" data-topicid="12883" href="/d/drug information/12883.html" rel="external">vitamin A</a> are low, children with acute or persistent diarrhea can develop eye lesions of vitamin A deficiency and become blind  (<a class="graphic graphic_picture graphicRef72297" href="/d/graphic/72297.html" rel="external">picture 3</a> and <a class="graphic graphic_picture graphicRef72148" href="/d/graphic/72148.html" rel="external">picture 4</a>). This is especially a problem when diarrhea occurs during or shortly after measles or in children who are already malnourished. (See  <a class="medical medical_review" href="/d/html/5360.html" rel="external">"Micronutrient deficiencies associated with protein-energy malnutrition in children", section on 'Vitamin A'</a> and  <a class="medical medical_review" href="/d/html/2571.html" rel="external">"Overview of vitamin A"</a>.)</p><p class="headingAnchor" id="H2319530433"><span class="h2">Central nervous system (CNS) involvement</span><span class="headingEndMark"> — </span>Manifestations of CNS involvement in the setting of diarrheal illness may include seizures and encephalopathy. These have been described in patients with severe disease due <em>to Shigella</em> and less commonly in systemic<em> Salmonella</em> infection [<a href="#rid20">20-23</a>]. </p><p>The presence of seizures should prompt consideration of hypoglycemia, hyponatremia, and hypernatremia. </p><p>Patients with bacterial meningitis and associated diarrhea may also present with seizures.</p><p class="headingAnchor" id="H1159942390"><span class="h1">CLINICAL ASSESSMENT</span><span class="headingEndMark"> — </span>Evaluation of a child with diarrhea should begin with a detailed clinical history of the duration, frequency, and character of the diarrhea. (See <a class="local">'Classification of diarrhea'</a> above.)</p><p>Clinical assessment should include the following:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Assessing hydration and nutrition status </strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Hydration status</strong> – An approach to assessment of hydration status based on four clinical signs has been issued by the World Health Organization (WHO)  (<a class="graphic graphic_table graphicRef68271" href="/d/graphic/68271.html" rel="external">table 3</a>) [<a href="#rid24">24-26</a>]. (See  <a class="medical medical_review" href="/d/html/6142.html" rel="external">"Clinical assessment of hypovolemia (dehydration) in children"</a>.)</p><p></p><p class="bulletIndent2">Following the initial assessment, ongoing fluid losses should be estimated based on the volume of emesis and stool. These assessments are essential for determining the volume, route, and pace of rehydration therapy needed.</p><p></p><p class="bulletIndent2">The presence or absence of individual signs and symptoms is not a useful predictor of hydration status. As examples: a sunken anterior fontanelle is a poor predictor of dehydration in infants; a patient who sheds tears may still be dehydrated; and hypotension is a late finding in children with dehydration (and may be absent even in severe dehydration) [<a href="#rid27">27</a>]. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Nutritional status</strong> – The approach to clinical assessment for malnutrition is outlined separately  (<a class="graphic graphic_table graphicRef60869" href="/d/graphic/60869.html" rel="external">table 2</a>). (See  <a class="medical medical_review" href="/d/html/5883.html" rel="external">"Malnutrition in children in resource-limited settings: Clinical assessment"</a>.)</p><p></p><p class="bulletIndent2">Children with acute diarrhea and malnutrition are at increased risk for fluid overload and heart failure during rehydration; therefore, such children require an individualized approach to rehydration and nutritional repletion. (See <a class="local">'Presence of severe malnutrition'</a> below.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Physical examination</strong> – Children with diarrhea should undergo a complete physical examination with careful attention to the following (see  <a class="medical medical_review" href="/d/html/2865.html" rel="external">"The pediatric physical examination: General principles and standard measurements"</a>): </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Temperature</strong> – Fever is common in the setting of diarrheal illness; however, the presence of fever or hypothermia should also prompt consideration of comorbid illnesses, such as pneumonia, sepsis, or malaria (in areas where endemic). </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Respiratory rate</strong> – The WHO uses the following definitions for tachypnea [<a href="#rid28">28</a>]:</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Infants &lt;2 months of age: ≥60 breaths/minute</p><p class="bulletIndent3"><span class="glyph">-</span>Infants 2 to 12 months of age: ≥50 breaths/minute</p><p class="bulletIndent3"><span class="glyph">-</span>Children 1 to 5 years of age: ≥40 breaths/minute</p><p class="bulletIndent3"><span class="glyph">-</span>Children ≥5 years of age: ≥20 breaths/minute (≥30 breaths/minute is a more specific threshold) </p><p></p><p class="bulletIndent2">Tachypnea may occur in patients with metabolic acidosis associated with dehydration, as well as in the setting of pneumonia [<a href="#rid29">29</a>]. (See <a class="local">'Role of antibiotics'</a> below.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Abdomen</strong> – Presence of abdominal pain should prompt consideration for an additional intrabdominal process, such as obstruction, intussusception, or appendicitis. (See  <a class="medical medical_review" href="/d/html/6434.html" rel="external">"Emergency evaluation of the child with acute abdominal pain"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Central nervous system (CNS)</strong> – Moderate dehydration may be associated with irritability; severe dehydration can lead to lethargy and coma. Other manifestations of CNS involvement in the setting of diarrheal illness include seizures and encephalopathy. (See <a class="local">'Central nervous system (CNS) involvement'</a> above.)</p><p></p><p class="bulletIndent2">Patients may present with bacterial meningitis and associated diarrhea; in infants with meningitis, meningeal signs may be absent. Therefore, the presence of any abnormal neurologic findings should prompt consideration of meningitis. (See  <a class="medical medical_review" href="/d/html/5968.html" rel="external">"Bacterial meningitis in children older than one month: Clinical features and diagnosis", section on 'Clinical features'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Eye exam</strong> – Patients should be examined for signs of <a class="drug drug_pediatric" data-topicid="12883" href="/d/drug information/12883.html" rel="external">vitamin A</a> deficiency; these include corneal clouding  (<a class="graphic graphic_picture graphicRef72297" href="/d/graphic/72297.html" rel="external">picture 3</a>) and conjunctival lesions (Bitot spot)  (<a class="graphic graphic_picture graphicRef72148" href="/d/graphic/72148.html" rel="external">picture 4</a>). (See <a class="local">'Malnutrition'</a> above.)</p><p></p><p class="headingAnchor" id="H1159942453"><span class="h1">DIAGNOSTIC EVALUATION</span><span class="headingEndMark"> — </span>The approach to diagnostic evaluation should be guided by clinical circumstances, as outlined below.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Watery diarrhea</strong> – It is important to distinguish cholera from other causes of acute watery diarrhea because patients with severe cholera may have more rapid fluid losses and typically benefit from antibiotic therapy. (See <a class="local">'Watery diarrhea'</a> above and  <a class="medical medical_review" href="/d/html/2704.html" rel="external">"Cholera: Epidemiology, clinical features, and diagnosis"</a>.)</p><p></p><p class="bulletIndent1">A definitive diagnosis of cholera is established by stool culture; supportive diagnostic tools include darkfield microscopy for detection of motile vibrios (which appear as “shooting stars”) or a stool dipstick.</p><p></p><p class="bulletIndent1">In the absence of diagnostic tools, patients with a short history (usually &lt;24 hours) of vomiting and voluminous watery diarrhea with a characteristic rice-water appearance  (<a class="graphic graphic_picture graphicRef52564" href="/d/graphic/52564.html" rel="external">picture 1</a>), especially in the setting of an outbreak, may be presumptively diagnosed with cholera based on clinical suspicion. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Invasive (bloody) diarrhea</strong> – For patients with invasive (bloody) diarrhea, stool culture is warranted if feasible. </p><p></p><p class="bulletIndent1">For patients who do not respond to antibiotic therapy (see <a class="local">'Role of antibiotics'</a> below), evaluation for<em> E. histolytica</em> is warranted via stool microscopy for the detection of trophozoites containing red blood cells  (<a class="graphic graphic_picture graphicRef57615" href="/d/graphic/57615.html" rel="external">picture 5</a>). (See  <a class="medical medical_review" href="/d/html/5727.html" rel="external">"Intestinal Entamoeba histolytica amebiasis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Additional manifestations</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Fever</strong> – For patients with fever in settings where malaria is endemic, further diagnostic evaluation is warranted. (See  <a class="medical medical_review" href="/d/html/5709.html" rel="external">"Malaria: Clinical manifestations and diagnosis in nonpregnant adults and children"</a>.) </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Abdominal pain</strong> – For patients with watery diarrhea and abdominal pain who are not responsive to initial rehydration, imaging studies are warranted. (See  <a class="medical medical_review" href="/d/html/6434.html" rel="external">"Emergency evaluation of the child with acute abdominal pain"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Respiratory distress</strong> – For patients with respiratory distress, reassessment following initial rehydration is warranted. For children with tachypnea in addition to cough and/or chest retractions, we favor presumptive treatment for pneumonia prior to the completion of rehydration. (See <a class="local">'Role of antibiotics'</a> below.) </p><p></p><p class="bulletIndent2">A chest radiograph is warranted for the evaluation of pneumonia, particularly in severely malnourished and dehydrated patients [<a href="#rid30">30-32</a>]. Further evaluation of children with respiratory distress is discussed separately. (See  <a class="medical medical_review" href="/d/html/6463.html" rel="external">"Acute respiratory distress in children: Emergency evaluation and initial stabilization"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Neurologic symptoms</strong> – For patients with neurologic symptoms, glucose and electrolyte assessments should be pursued. The approach to the evaluation of meningitis in children is discussed separately. (See  <a class="medical medical_review" href="/d/html/5968.html" rel="external">"Bacterial meningitis in children older than one month: Clinical features and diagnosis"</a>.)</p><p></p><p class="headingAnchor" id="H1159942460"><span class="h1">MANAGEMENT</span></p><p class="headingAnchor" id="H3029670192"><span class="h2">Absence of severe malnutrition</span><span class="headingEndMark"> — </span>In the absence of severe malnutrition (see <a class="local">'Clinical assessment'</a> above), treatment of children with acute diarrhea consists of correcting fluid and electrolyte losses, administering appropriate nutrition, and managing associated comorbid conditions [<a href="#rid1">1</a>]. Antibiotic therapy is warranted in some circumstances, as outlined below.</p><p class="headingAnchor" id="H1159942469"><span class="h3">Fluid and electrolytes</span><span class="headingEndMark"> — </span>Rehydration therapy is critical for management of diarrhea. The goal of replacement therapy is to replenish deficits in water and electrolytes lost. (See  <a class="medical medical_review" href="/d/html/138933.html" rel="external">"Shock in children in resource-limited settings: Initial management"</a> and  <a class="medical medical_review" href="/d/html/6103.html" rel="external">"Treatment of hypovolemia (dehydration) in children in resource-abundant settings"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Phases of treatment</strong> – Fluid management consists of two phases: replacement and maintenance. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Replacement</strong> – Treatment begins with the replacement phase, which continues until all signs and symptoms of volume depletion have resolved and the patient has urinated; ideally, this is achieved during the first four hours of treatment. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Maintenance</strong> – The maintenance phase counters ongoing losses of water and electrolytes; this phase continues until diarrhea and other signs and symptoms of illness have resolved. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical approach</strong> – The approach to fluid and electrolyte management depends on the degree of dehydration. The WHO provides definitions and treatment guidelines along a continuum that includes "no dehydration" (Plan A), "some dehydration" (Plan B), and "severe dehydration" (Plan C) [<a href="#rid33">33</a>]: </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>No signs of dehydration (Plan A)</strong> – This category includes children with &lt;5 percent dehydration  (<a class="graphic graphic_table graphicRef68271" href="/d/graphic/68271.html" rel="external">table 3</a>). </p><p></p><p class="bulletIndent3"><span class="glyph">-</span><strong>Site of care</strong> – Patients with no signs of dehydration do not require replacement therapy and can begin maintenance therapy. Hospital admission is not usually required; patients may be sent home after a brief period of observation to verify that they are tolerating oral maintenance fluids. </p><p></p><p class="bulletIndent3"><span class="glyph">-</span><strong>Maintenance fluid</strong> – Ideally, oral rehydration solution (ORS), a mixture of water, salts, and glucose, should be administered to counter ongoing fluid and electrolyte losses  (<a class="graphic graphic_table graphicRef62757" href="/d/graphic/62757.html" rel="external">table 4</a>). In general, children ≤2 years old should receive approximately 50 to 100 mL of ORS for each episode of diarrhea or vomiting; children &gt;2 years old should receive 100 to 200 mL of ORS for each episode. (See  <a class="medical medical_review" href="/d/html/6129.html" rel="external">"Oral rehydration therapy"</a>.)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span><strong>Supplemental fluid</strong> – If the stool output is modest (eg, no more than three loose stools/day or under 10 g/kg of stool per day), ORS may not be necessary; ongoing feeding along with supplemental fluids  (<a class="graphic graphic_table graphicRef82172" href="/d/graphic/82172.html" rel="external">table 5</a>) may be sufficient. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Some dehydration (Plan B)</strong> – This category includes children with 5 to 10 percent dehydration  (<a class="graphic graphic_table graphicRef68271" href="/d/graphic/68271.html" rel="external">table 3</a>). </p><p></p><p class="bulletIndent3"><span class="glyph">-</span><strong>Site of care</strong> – Patients with some dehydration warrant replacement therapy with ORS in a supervised setting.</p><p></p><p class="bulletIndent3"><span class="glyph">-</span><strong>Replacement fluid</strong> – The replacement fluid volume should be guided by patient age and weight, as outlined in the table  (<a class="graphic graphic_table graphicRef57007" href="/d/graphic/57007.html" rel="external">table 6</a>). </p><p></p><p class="bulletIndent3">If ongoing stool losses are profound, these losses may be added to the initial replacement fluid given over the initial four hours of treatment. Stool output may be measured by collecting stool using a cholera cot  (<a class="graphic graphic_picture graphicRef70839" href="/d/graphic/70839.html" rel="external">picture 6</a>). Alternatively, stool output may be estimated at 10 to 20 mL/kg of body weight for each diarrheal stool.</p><p></p><p class="bulletIndent3">Replacement fluids should be continued under supervision until there are no signs of dehydration and the patient has urinated. This may require more fluid volume than initially estimated; frequent reassessment of hydration status is essential. </p><p></p><p class="bulletIndent3"><span class="glyph">-</span><strong>Maintenance fluid</strong> – Once dehydration has been corrected, the administration of maintenance fluid (ideally ORS) to counter ongoing losses can be managed as for patients with no signs of dehydration (outlined above).</p><p></p><p class="bulletIndent2">Children with profound ongoing stool losses termed high purging (≥15 mL/kg per hour; such as seen in cholera) or with persistent vomiting (≥3 episodes per hour) may fail repeated attempts at oral rehydration or progress to severe dehydration; this occurs in approximately 3 to 5 percent of patients [<a href="#rid34">34</a>]. Such patients require intravenous (IV) correction for severe dehydration, as outlined below.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Severe dehydration (Plan C) </strong>– This category includes children with &gt;10 percent dehydration  (<a class="graphic graphic_table graphicRef68271" href="/d/graphic/68271.html" rel="external">table 3</a>). According to the WHO, severe dehydration is an emergency sign that essentially requires treatment with IV fluids, even if the patient does not meet the WHO clinical or systolic blood pressure criteria for shock  (<a class="graphic graphic_table graphicRef143014" href="/d/graphic/143014.html" rel="external">table 7</a> and <a class="graphic graphic_table graphicRef143095" href="/d/graphic/143095.html" rel="external">table 8</a>). </p><p></p><p class="bulletIndent2">The WHO plan C provides recommendations for fluid repletion of severe dehydration for these patients that vary by the degree of anemia and malnutrition as shown in the algorithm  (<a class="graphic graphic_algorithm graphicRef143300" href="/d/graphic/143300.html" rel="external">algorithm 1</a>) and discussed separately. (See  <a class="medical medical_review" href="/d/html/138933.html" rel="external">"Shock in children in resource-limited settings: Initial management", section on 'Severe dehydration (The WHO plan C)'</a>.) </p><p></p><p class="bulletIndent2">The WHO plan C also provides guidance on fluid management and transfer to a higher level of care for children with severe dehydration in settings where IV or intraosseous access is not available  (<a class="graphic graphic_algorithm graphicRef142543" href="/d/graphic/142543.html" rel="external">algorithm 2</a>).</p><p></p><p class="headingAnchor" id="H3321759446"><span class="h3">Role of antibiotics</span><span class="headingEndMark"> — </span>Use of antibiotics should be guided by clinical circumstances, as outlined below.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Patients with watery diarrhea </strong>– For patients with known or suspected cholera in the setting of moderate to severe volume depletion, and for patients with known or suspected cholera in the setting of an epidemic, antibiotic therapy is warranted  (<a class="graphic graphic_table graphicRef71548" href="/d/graphic/71548.html" rel="external">table 9</a>). (See  <a class="medical medical_review" href="/d/html/2704.html" rel="external">"Cholera: Epidemiology, clinical features, and diagnosis"</a>.)</p><p></p><p class="bulletIndent1">For patients with watery diarrhea in the absence of the above factors, there is no role for routine antibiotic therapy. </p><p></p><p class="bulletIndent1">The above approach is supported by a randomized trial including more than 8000 children in a resource-limited setting. Patients were randomly assigned to receive <a class="drug drug_pediatric" data-topicid="12937" href="/d/drug information/12937.html" rel="external">azithromycin</a> or placebo for three days; antibiotic treatment did not confer a survival benefit from empiric azithromycin [<a href="#rid35">35</a>]. There was a small reduction in growth faltering among those who received antibiotics, although the magnitude was not likely to be clinically significant. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Patients with invasive (bloody) diarrhea</strong> </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Empiric treatment for </strong><strong><em>Shigella</em></strong><strong> infection</strong> – For patients with invasive diarrhea, empiric antibiotic therapy with activity against <em>Shigella</em> species is warranted  (<a class="graphic graphic_table graphicRef88651" href="/d/graphic/88651.html" rel="external">table 10</a>).</p><p></p><p class="bulletIndent2">Antimicrobial treatment of <em>Shigella</em> infection reduces the duration of fever and diarrhea, reduces the duration of bacterial shedding, and may reduce the risk of life-threatening complications of infection such as bacteremia and encephalopathy [<a href="#rid20">20,21,36</a>]. (See  <a class="medical medical_review" href="/d/html/6003.html" rel="external">"Shigella infection: Treatment and prevention in children", section on 'Antibiotic therapy'</a>.)</p><p></p><p class="bulletIndent2">Antibiotic therapy should be tailored to culture and susceptibility data, if available. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Patients with persistent symptoms </strong>– For patients with invasive diarrhea that does not remit within two days of starting empiric antibiotic therapy, switching to an alternative antimicrobial agent is warranted  (<a class="graphic graphic_table graphicRef88651" href="/d/graphic/88651.html" rel="external">table 10</a>).</p><p></p><p class="bulletIndent2">For patients with persistent symptoms after two days of treatment with an alternative antibiotic agent, evaluation for amebiasis (an unusual cause of invasive diarrhea) is warranted. (See <a class="local">'Infectious causes'</a> above and <a class="local">'Diagnostic evaluation'</a> above.) </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Patients with amebiasis</strong> – Treatment of amebiasis consists of <a class="drug drug_pediatric" data-topicid="12606" href="/d/drug information/12606.html" rel="external">metronidazole</a> (35 to 50 mg/kg per day in three divided doses for 7 to 10 days in children; maximum 750 mg orally, three times daily). (See  <a class="medical medical_review" href="/d/html/5727.html" rel="external">"Intestinal Entamoeba histolytica amebiasis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Patients with severe acute malnutrition </strong>– Patients with diarrhea and severe acute malnutrition should be treated with empiric broad-spectrum antibiotics [<a href="#rid1">1,37</a>]. This is discussed further separately. (See  <a class="medical medical_review" href="/d/html/5901.html" rel="external">"Management of complicated severe acute malnutrition in children in resource-limited settings", section on 'Empiric antibiotics'</a> and  <a class="medical medical_review" href="/d/html/113959.html" rel="external">"Management of uncomplicated severe acute malnutrition in children in resource-limited settings", section on 'Antibiotics'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Patients with tachypnea as well as cough and/or chest retractions</strong> – For children with tachypnea in addition to cough and/or chest retractions, we favor presumptive treatment for pneumonia prior to completion of rehydration [<a href="#rid29">29</a>]. For children with tachypnea in the absence of other respiratory symptoms, we reassess the need for antibiotic treatment following initial rehydration. </p><p></p><p class="headingAnchor" id="H41952187"><span class="h3">Nutrition</span><span class="headingEndMark"> — </span>For patients with acute diarrhea in the absence of malnutrition, sufficient feeding should be encouraged (during as well as after the diarrheal episode) to prevent the development of malnutrition and chronic enteropathy. The approach for patients with severe malnutrition is discussed separately. (See <a class="local">'Presence of severe malnutrition'</a> below.)</p><p>Infants with diarrhea should be encouraged to breastfeed as much as possible [<a href="#rid1">1</a>]. Infants who are not breastfed should be encouraged to continue to take undiluted formula at least every three hours. </p><p>Children with diarrhea should be encouraged to take solid foods immediately after initial dehydration is corrected [<a href="#rid38">38</a>]. Delaying the initiation of a nutrient-rich diet may increase the risk of malnutrition. </p><p>As long as diarrhea persists, foods high in energy content and micronutrients should be offered at frequent intervals (at least six meals a day). After the diarrhea resolves, at least one extra meal per day should be continued for a minimum of two weeks, or until the patient regains normal weight-for-height [<a href="#rid1">1</a>].</p><p class="headingAnchor" id="H237061221"><span class="h3">Vitamins and minerals</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Zinc</strong> – We are in agreement with the WHO, which recommends zinc supplementation for children with diarrhea [<a href="#rid1">1</a>]. We administer zinc supplementation to children 6 months to 5 years of age at a dose of 10 mg/day for 14 days.</p><p></p><p class="bulletIndent1">Zinc supplementation is supported by a 2016 meta-analysis including 33 trials and more than 10,000 children ages one month to five years with diarrhea. Among 2581 children &gt;6 months of age in nine trials, zinc supplementation shortened the duration of diarrhea by approximately half a day (mean duration -11.46 hours, 95% CI -19.72 to -3.19) [<a href="#rid39">39</a>]. Among 419 children with signs of malnutrition in five trials, zinc supplementation shortened the duration of diarrhea by around a day (mean duration 26.39 hours, 95% CI -36.54 to -16.23).</p><p></p><p class="bulletIndent1">Our dosing approach differs from that of the WHO, given the association of zinc supplementation with vomiting [<a href="#rid39">39,40</a>]. One randomized trial including more than 4500 children (age 6 to 59 months) found that a daily zinc dose of 10 mg or 5 mg was associated with a lower risk of vomiting than 20 mg (relative risk of vomiting 0.81 [97.5% CI 0.57-0.96] for 10 mg and 0.71 [97.5% CI 0.59-0.86] for 5 mg) and comparable efficacy for the treatment of diarrhea [<a href="#rid41">41</a>]. Based on these findings, we favor a zinc dose of 10 mg for 14 days, pending further guidance from the WHO.</p><p></p><p class="bulletIndent1">Issues related to zinc deficiency and supplementation are discussed further separately. (See  <a class="medical medical_review" href="/d/html/5354.html" rel="external">"Zinc deficiency and supplementation in children"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Vitamin A</strong> – Administration of <a class="drug drug_pediatric" data-topicid="12883" href="/d/drug information/12883.html" rel="external">vitamin A</a> is warranted for patients with acute diarrhea who have signs and symptoms of vitamin A deficiency (such as xerophthalmia, keratitis, keratoconjunctivitis, corneal ulceration, or Bitot spots). (See <a class="local">'Clinical assessment'</a> above.)</p><p></p><p class="bulletIndent1"><a class="drug drug_pediatric" data-topicid="12883" href="/d/drug information/12883.html" rel="external">Vitamin A</a> dosing is outlined separately. (See  <a class="medical medical_review" href="/d/html/2571.html" rel="external">"Overview of vitamin A", section on 'Replacement'</a>.)</p><p></p><p class="bulletIndent1">In addition, routine <a class="drug drug_pediatric" data-topicid="12883" href="/d/drug information/12883.html" rel="external">vitamin A</a> supplementation has been associated with reducing morbidity and mortality among children in resource-limited settings. (See  <a class="medical medical_review" href="/d/html/2571.html" rel="external">"Overview of vitamin A", section on 'Deficiency'</a>.) </p><p></p><p class="headingAnchor" id="H1159942546"><span class="h3">Limited role for other interventions</span><span class="headingEndMark"> — </span>The mainstays of treatment for children with acute diarrhea in resource-limited settings include the interventions outlined above. No additional therapies have well established benefits, and some are potentially harmful. </p><p></p><p>We do not favor routine use of antimotility agents or antiemetics in children with acute diarrhea. Antimotility agents (such as <a class="drug drug_pediatric" data-topicid="12561" href="/d/drug information/12561.html" rel="external">loperamide</a>, <a class="drug drug_pediatric" data-topicid="13237" href="/d/drug information/13237.html" rel="external">diphenoxylate-atropine</a>, and <a class="drug drug_pediatric" data-topicid="12661" href="/d/drug information/12661.html" rel="external">tincture of opium</a>) prolong some bacterial infections and have been associated with rare cases of fatal paralytic ileus [<a href="#rid42">42</a>]. Antiemetics (such as <a class="drug drug_pediatric" data-topicid="12659" href="/d/drug information/12659.html" rel="external">ondansetron</a>, <a class="drug drug_pediatric" data-topicid="12602" href="/d/drug information/12602.html" rel="external">metoclopramide</a>, and <a class="drug drug_pediatric" data-topicid="12735" href="/d/drug information/12735.html" rel="external">promethazine</a>) have sedating effects that can interfere with rehydration and may cause extrapyramidal reactions and respiratory depression [<a href="#rid1">1</a>]. </p><p class="headingAnchor" id="H1435635745"><span class="h2">Presence of severe malnutrition</span><span class="headingEndMark"> — </span>Children with acute diarrhea and severe malnutrition require an individualized approach to rehydration and nutritional repletion. These issues are discussed further separately. (See  <a class="medical medical_review" href="/d/html/5901.html" rel="external">"Management of complicated severe acute malnutrition in children in resource-limited settings", section on 'Dehydration'</a> and  <a class="medical medical_review" href="/d/html/138933.html" rel="external">"Shock in children in resource-limited settings: Initial management", section on 'Severe dehydration (The WHO plan C)'</a>.) </p><p class="headingAnchor" id="H1159942574"><span class="h1">PREVENTION</span><span class="headingEndMark"> — </span>Interventions for the prevention of diarrhea include [<a href="#rid1">1</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Immunization</strong> – Vaccination against measles, rotavirus, and cholera is an important tool for the prevention of diarrhea. (See  <a class="medical medical_review" href="/d/html/3021.html" rel="external">"Measles: Clinical manifestations, diagnosis, treatment, and prevention", section on 'Measles, mumps, and rubella vaccination'</a> and  <a class="medical medical_review" href="/d/html/6023.html" rel="external">"Rotavirus vaccines for infants"</a> and  <a class="medical medical_review" href="/d/html/2704.html" rel="external">"Cholera: Epidemiology, clinical features, and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Breastfeeding</strong> – The World Health Organization (WHO) recommends exclusive breastfeeding until age six months, followed by continued breastfeeding with complementary foods until two years of age. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hygiene</strong> – Use of clean water, food safety practices, handwashing, and latrines.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Nutrition</strong> – Optimizing nutritional status is important for the prevention of poor outcomes related to diarrheal illness. In areas where <a class="drug drug_pediatric" data-topicid="12883" href="/d/drug information/12883.html" rel="external">vitamin A</a> deficiency is common, routine vitamin A supplementation has been associated with reducing morbidity and mortality. (See  <a class="medical medical_review" href="/d/html/2571.html" rel="external">"Overview of vitamin A", section on 'Deficiency'</a>.)</p><p></p><p class="headingAnchor" id="H1268580060"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/110029.html" rel="external">"Society guideline links: Acute diarrhea in children"</a>.)</p><p class="headingAnchor" id="H4266688"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Classification and etiology</strong> – Diarrhea refers to the passage of loose or watery stools at least three times in a 24-hour period. Acute diarrhea refers to &lt;14 days of symptoms. Most cases of acute diarrhea in resource-limited settings are caused by infectious gastroenteritis; patients may present with watery diarrhea or invasive (bloody) diarrhea. The microbial etiology is summarized in the table  (<a class="graphic graphic_table graphicRef50975" href="/d/graphic/50975.html" rel="external">table 1</a>). (See <a class="local">'Etiology'</a> above and <a class="local">'Classification of diarrhea'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical manifestations and complications</strong> – Clinical manifestations and complications of acute diarrhea include dehydration, electrolyte disturbances, and malnutrition. Manifestations of central nervous system (CNS) involvement may include seizures and encephalopathy. (See <a class="local">'Clinical manifestations and complications'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical assessment</strong> – Clinical evaluation should include assessment of hydration  (<a class="graphic graphic_table graphicRef68271" href="/d/graphic/68271.html" rel="external">table 3</a>) and nutrition status  (<a class="graphic graphic_table graphicRef60869" href="/d/graphic/60869.html" rel="external">table 2</a>), as well as a complete physical examination. (See <a class="local">'Clinical assessment'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnostic evaluation</strong> – The approach to diagnostic evaluation should be guided by clinical circumstances (see <a class="local">'Diagnostic evaluation'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Watery diarrhea</strong> – It is important to distinguish cholera from other causes of acute watery diarrhea since patients with severe cholera may have more rapid fluid losses and typically benefit from antibiotic therapy. A definitive diagnosis of cholera is established by stool culture; supportive diagnostic tools include darkfield microscopy (for the detection of motile vibrios) or a stool dipstick. </p><p></p><p class="bulletIndent2">In the absence of diagnostic tools, patients with a short history (usually &lt;24 hours) of vomiting and voluminous watery diarrhea with characteristic rice-water appearance (especially in the setting of an outbreak) may be presumptively diagnosed with cholera based on clinical suspicion.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Invasive (bloody) diarrhea</strong> – For patients with invasive diarrhea, stool culture is warranted if feasible. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Management in absence of severe malnutrition</strong> – In general, management of children with acute diarrhea consists of correcting fluid and electrolyte losses, administering appropriate nutrition, and assessing the need for antibiotics. (See <a class="local">'Management'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Fluid and electrolytes</strong> – The approach to fluid and electrolyte management depends on the degree of dehydration  (<a class="graphic graphic_table graphicRef68271" href="/d/graphic/68271.html" rel="external">table 3</a>) (see <a class="local">'Fluid and electrolytes'</a> above):</p><p></p><p class="bulletIndent3"><span class="glyph">-</span><strong>No signs of dehydration</strong> (&lt;5 percent dehydration, Plan A) – Management consists of maintenance therapy with oral rehydration solution (ORS)  (<a class="graphic graphic_table graphicRef62757" href="/d/graphic/62757.html" rel="external">table 4</a>). In general, children ≤2 years of age should receive approximately 50 to 100 mL of ORS for each episode of diarrhea or vomiting; children &gt;2 years should receive 100 to 200 mL of ORS for each episode. </p><p></p><p class="bulletIndent3"><span class="glyph">-</span><strong>Some dehydration</strong> (5 to 10 percent, Plan B) – Management consists of replacement therapy with ORS (guided by age and weight  (<a class="graphic graphic_table graphicRef57007" href="/d/graphic/57007.html" rel="external">table 6</a>)) in a supervised setting. Stool output may be collected or estimated (10 to 20 mL/kg of body weight for each diarrheal stool). Replacement fluids should be continued under supervision until there are no signs of dehydration and the patient has urinated. This may require more fluid volume than initially estimated; frequent reassessment of hydration status is essential. </p><p></p><p class="bulletIndent3"><span class="glyph">-</span><strong>Severe dehydration</strong> (&gt;10 percent, Plan C) – Management consists of urgent treatment with intravenous (IV) isotonic crystalloid fluids in a hospital setting; fluid therapy varies by the degree of anemia and malnutrition as shown in the algorithm  (<a class="graphic graphic_algorithm graphicRef143300" href="/d/graphic/143300.html" rel="external">algorithm 1</a>) and discussed separately. (See  <a class="medical medical_review" href="/d/html/138933.html" rel="external">"Shock in children in resource-limited settings: Initial management", section on 'Severe dehydration (The WHO plan C)'</a>.). </p><p></p><p class="bulletIndent3">The WHO plan C also provides guidance on fluid management and transfer to a higher level of care for children with severe dehydration in settings where IV or intraosseous access is not available  (<a class="graphic graphic_algorithm graphicRef142543" href="/d/graphic/142543.html" rel="external">algorithm 2</a>).</p><p></p><p class="bulletIndent3"><span class="glyph">-</span><strong>Patients with seizures</strong> – If seizures are present (and hypoglycemia is suspected), a rapid bolus of IV glucose should be given, followed by addition of 5% glucose to the IV fluid. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Role of antibiotics</strong> (see <a class="local">'Role of antibiotics'</a> above):</p><p></p><p class="bulletIndent3"><span class="glyph">-</span><strong>Watery diarrhea</strong> – For patients with known or suspected cholera in the setting of moderate to severe volume depletion, and for patients with known or suspected cholera in the setting of an epidemic, antibiotic therapy is warranted; selection and dosing are summarized in the table  (<a class="graphic graphic_table graphicRef71548" href="/d/graphic/71548.html" rel="external">table 9</a>). Issues related to cholera are discussed separately. (See  <a class="medical medical_review" href="/d/html/2704.html" rel="external">"Cholera: Epidemiology, clinical features, and diagnosis"</a>.)</p><p></p><p class="bulletIndent3">For patients with watery diarrhea in the absence of the above factors, we suggest not treating with antibiotics (<a class="grade" href="https://medilib.ir/uptodate/show/grade_5" rel="external">Grade 2B</a>). </p><p></p><p class="bulletIndent3"><span class="glyph">-</span><strong>Invasive (bloody) diarrhea</strong> – For patients with invasive diarrhea, antibiotic therapy with activity against <em>Shigella</em> species is warranted; selection and dosing are summarized in the table  (<a class="graphic graphic_table graphicRef88651" href="/d/graphic/88651.html" rel="external">table 10</a>). Issues related to <em>Shigella</em> infection are discussed separately. (See  <a class="medical medical_review" href="/d/html/6003.html" rel="external">"Shigella infection: Treatment and prevention in children"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Nutrition, vitamins, and minerals</strong> – For patients with acute diarrhea in the absence of malnutrition, sufficient feeding should be encouraged. (See <a class="local">'Nutrition'</a> above and <a class="local">'Vitamins and minerals'</a> above.)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span><strong>Zinc</strong> – For children six months to five years of age with acute diarrhea, we suggest zinc administration (<a class="grade" href="https://medilib.ir/uptodate/show/grade_5" rel="external">Grade 2B</a>); dosing is outlined above. </p><p></p><p class="bulletIndent3"><span class="glyph">-</span><strong>Vitamin A</strong> – Children with signs of <a class="drug drug_pediatric" data-topicid="12883" href="/d/drug information/12883.html" rel="external">vitamin A</a> deficiency require vitamin A administration. Vitamin A dosing is outlined separately. (See  <a class="medical medical_review" href="/d/html/2571.html" rel="external">"Overview of vitamin A", section on 'Replacement'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Management in presence of severe malnutrition</strong> – Management of children with acute diarrhea and severe malnutrition is discussed further separately. (See  <a class="medical medical_review" href="/d/html/5901.html" rel="external">"Management of complicated severe acute malnutrition in children in resource-limited settings", section on 'Dehydration'</a> and  <a class="medical medical_review" href="/d/html/5878.html" rel="external">"Persistent diarrhea in children in resource-limited settings", section on 'Rehydration'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Prevention</strong> – Tools for prevention of diarrhea include immunization against vaccine-preventable diseases, breastfeeding, and attention to good hygiene practices. (See <a class="local">'Prevention'</a> above.) </p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li class="breakAll">World Health Organization. The treatment of diarrhoea, a manual for physicians and other senior health workers. 4th revision. WHO/FCH/CAH/05.1. Geneva: World Health Organization, 2005. https://apps.who.int/iris/handle/10665/43209 (Accessed on December 11, 2023).</li><li class="breakAll">https://data.unicef.org/topic/child-health/diarrhoeal-disease/ (Accessed on June 07, 2023).</li><li><a class="nounderline abstract_t">Reiner RC Jr, Graetz N, Casey DC, et al. Variation in Childhood Diarrheal Morbidity and Mortality in Africa, 2000-2015. N Engl J Med 2018; 379:1128.</a></li><li><a class="nounderline abstract_t">Local Burden of Disease Diarrhoea Collaborators. Mapping geographical inequalities in childhood diarrhoeal morbidity and mortality in low-income and middle-income countries, 2000-17: analysis for the Global Burden of Disease Study 2017. Lancet 2020; 395:1779.</a></li><li><a class="nounderline abstract_t">Kotloff KL, Nataro JP, Blackwelder WC, et al. Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study. Lancet 2013; 382:209.</a></li><li><a class="nounderline abstract_t">Liu J, Platts-Mills JA, Juma J, et al. Use of quantitative molecular diagnostic methods to identify causes of diarrhoea in children: a reanalysis of the GEMS case-control study. Lancet 2016; 388:1291.</a></li><li><a class="nounderline abstract_t">Pavlinac PB, Platts-Mills J, Liu J, et al. Azithromycin for bacterial watery diarrhea: A reanalysis of the AntiBiotics for Children with severe Diarrhea (ABCD) trial incorporating molecular diagnostics. J Infect Dis 2023.</a></li><li><a class="nounderline abstract_t">Rouhani S, Peñataro Yori P, Paredes Olortegui M, et al. Norovirus Infection and Acquired Immunity in 8 Countries: Results From the MAL-ED Study. Clin Infect Dis 2016; 62:1210.</a></li><li><a class="nounderline abstract_t">Baker JM, Hasso-Agopsowicz M, Pitzer VE, et al. Association of enteropathogen detection with diarrhoea by age and high versus low child mortality settings: a systematic review and meta-analysis. Lancet Glob Health 2021; 9:e1402.</a></li><li><a class="nounderline abstract_t">Operario DJ, Platts-Mills JA, Nadan S, et al. Etiology of Severe Acute Watery Diarrhea in Children in the Global Rotavirus Surveillance Network Using Quantitative Polymerase Chain Reaction. J Infect Dis 2017; 216:220.</a></li><li><a class="nounderline abstract_t">Huilan S, Zhen LG, Mathan MM, et al. Etiology of acute diarrhoea among children in developing countries: a multicentre study in five countries. Bull World Health Organ 1991; 69:549.</a></li><li><a class="nounderline abstract_t">Kotloff KL, Winickoff JP, Ivanoff B, et al. Global burden of Shigella infections: implications for vaccine development and implementation of control strategies. Bull World Health Organ 1999; 77:651.</a></li><li><a class="nounderline abstract_t">Ryan ET, Dhar U, Khan WA, et al. Mortality, morbidity, and microbiology of endemic cholera among hospitalized patients in Dhaka, Bangladesh. Am J Trop Med Hyg 2000; 63:12.</a></li><li><a class="nounderline abstract_t">Heyman SN, Ginosar Y, Shapiro M, et al. Diarrheal epidemics among Rwandan refugees in 1994. Management and outcome in a field hospital. J Clin Gastroenterol 1997; 25:595.</a></li><li><a class="nounderline abstract_t">Ahmed T, Ali M, Ullah MM, et al. Mortality in severely malnourished children with diarrhoea and use of a standardised management protocol. Lancet 1999; 353:1919.</a></li><li><a class="nounderline abstract_t">Butler T, Islam M, Azad AK, et al. Causes of death in diarrhoeal diseases after rehydration therapy: an autopsy study of 140 patients in Bangladesh. Bull World Health Organ 1987; 65:317.</a></li><li><a class="nounderline abstract_t">Bryce J, Boschi-Pinto C, Shibuya K, et al. WHO estimates of the causes of death in children. Lancet 2005; 365:1147.</a></li><li><a class="nounderline abstract_t">Guerrant RL, Oriá RB, Moore SR, et al. Malnutrition as an enteric infectious disease with long-term effects on child development. Nutr Rev 2008; 66:487.</a></li><li><a class="nounderline abstract_t">Petri WA Jr, Miller M, Binder HJ, et al. Enteric infections, diarrhea, and their impact on function and development. J Clin Invest 2008; 118:1277.</a></li><li><a class="nounderline abstract_t">Chisti MJ, Faruque AS, Khan WA, et al. Characteristics of children with Shigella encephalopathy: experience from a large urban diarrhea treatment center in Bangladesh. Pediatr Infect Dis J 2010; 29:444.</a></li><li><a class="nounderline abstract_t">Afroze F, Ahmed T, Sarmin M, et al. Risk factors and outcome of Shigella encephalopathy in Bangladeshi children. PLoS Negl Trop Dis 2017; 11:e0005561.</a></li><li><a class="nounderline abstract_t">Leung DT, Bogetz J, Itoh M, et al. Factors associated with encephalopathy in patients with Salmonella enterica serotype Typhi bacteremia presenting to a diarrheal hospital in Dhaka, Bangladesh. Am J Trop Med Hyg 2012; 86:698.</a></li><li><a class="nounderline abstract_t">Chisti MJ, Bardhan PK, Huq S, et al. High-dose intravenous dexamethasone in the management of diarrheal patients with enteric fever and encephalopathy. Southeast Asian J Trop Med Public Health 2009; 40:1065.</a></li><li><a class="nounderline abstract_t">Gorelick MH, Shaw KN, Murphy KO. Validity and reliability of clinical signs in the diagnosis of dehydration in children. Pediatrics 1997; 99:E6.</a></li><li><a class="nounderline abstract_t">Duggan C, Refat M, Hashem M, et al. How valid are clinical signs of dehydration in infants? J Pediatr Gastroenterol Nutr 1996; 22:56.</a></li><li><a class="nounderline abstract_t">Steiner MJ, DeWalt DA, Byerley JS. Is this child dehydrated? JAMA 2004; 291:2746.</a></li><li><a class="nounderline abstract_t">King CK, Glass R, Bresee JS, et al. Managing acute gastroenteritis among children: oral rehydration, maintenance, and nutritional therapy. MMWR Recomm Rep 2003; 52:1.</a></li><li class="breakAll">World Health Organization. The management of acute respiratory infections in children. In: Practical guidelines for outpatient care. World Health Organization, Geneva, 1995.</li><li><a class="nounderline abstract_t">Nuzhat S, Ahmed T, Kawser CA, et al. Age specific fast breathing in under-five diarrheal children in an urban hospital: Acidosis or pneumonia? PLoS One 2017; 12:e0185414.</a></li><li><a class="nounderline abstract_t">Chisti MJ, Ahmed T, Faruque AS, Abdus Salam M. Clinical and laboratory features of radiologic pneumonia in severely malnourished infants attending an urban diarrhea treatment center in Bangladesh. Pediatr Infect Dis J 2010; 29:174.</a></li><li><a class="nounderline abstract_t">Chisti MJ, Tebruegge M, La Vincente S, et al. Pneumonia in severely malnourished children in developing countries - mortality risk, aetiology and validity of WHO clinical signs: a systematic review. Trop Med Int Health 2009; 14:1173.</a></li><li><a class="nounderline abstract_t">Chisti MJ, Huq S, Das SK, et al. Predictors of severe illness in children under age five with concomitant infection with pneumonia and diarrhea at a large hospital in Dhaka, Bangladesh. Southeast Asian J Trop Med Public Health 2008; 39:719.</a></li><li class="breakAll">WHO Guideline: Updates on Paediatric Emergency Triage, Assessment and Treatment: Care of Critically-ill Children. Geneva, Switzerland, World Health Organization, 2016. https://apps.who.int/iris/bitstream/handle/10665/204463/9789241510219_eng.pdf (Accessed on October 10, 2023).</li><li><a class="nounderline abstract_t">Hartling L, Bellemare S, Wiebe N, et al. Oral versus intravenous rehydration for treating dehydration due to gastroenteritis in children. Cochrane Database Syst Rev 2006; :CD004390.</a></li><li><a class="nounderline abstract_t">Antibiotics for Children With Diarrhea (ABCD) Study Group, Ahmed T, Chisti MJ, et al. Effect of 3 Days of Oral Azithromycin on Young Children With Acute Diarrhea in Low-Resource Settings: A Randomized Clinical Trial. JAMA Netw Open 2021; 4:e2136726.</a></li><li><a class="nounderline abstract_t">Christopher PR, David KV, John SM, Sankarapandian V. Antibiotic therapy for Shigella dysentery. Cochrane Database Syst Rev 2009; :CD006784.</a></li><li class="breakAll">Management of severe malnutrition: A manual for physicians and other senior health workers. World Health Organization, Geneva 1999. http://apps.who.int/iris/bitstream/handle/10665/41999/a57361.pdf?sequence=1 (Accessed on April 07, 2023).</li><li><a class="nounderline abstract_t">Gregorio GV, Dans LF, Silvestre MA. Early versus Delayed Refeeding for Children with Acute Diarrhoea. Cochrane Database Syst Rev 2011; :CD007296.</a></li><li><a class="nounderline abstract_t">Lazzerini M, Wanzira H. Oral zinc for treating diarrhoea in children. Cochrane Database Syst Rev 2016; 12:CD005436.</a></li><li><a class="nounderline abstract_t">Lukacik M, Thomas RL, Aranda JV. A meta-analysis of the effects of oral zinc in the treatment of acute and persistent diarrhea. Pediatrics 2008; 121:326.</a></li><li><a class="nounderline abstract_t">Dhingra U, Kisenge R, Sudfeld CR, et al. Lower-Dose Zinc for Childhood Diarrhea - A Randomized, Multicenter Trial. N Engl J Med 2020; 383:1231.</a></li><li><a class="nounderline abstract_t">Li ST, Grossman DC, Cummings P. Loperamide therapy for acute diarrhea in children: systematic review and meta-analysis. PLoS Med 2007; 4:e98.</a></li></ol></div><div id="topicVersionRevision">Topic 13956 Version 30.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://apps.who.int/iris/handle/10665/43209" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : World Health Organization. The treatment of diarrhoea, a manual for physicians and other senior health workers. 4th revision. WHO/FCH/CAH/05.1. Geneva: World Health Organization, 2005. https://apps.who.int/iris/handle/10665/43209 (Accessed on December 11, 2023).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://data.unicef.org/topic/child-health/diarrhoeal-disease/" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : https://data.unicef.org/topic/child-health/diarrhoeal-disease/ (Accessed on June 07, 2023).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30231224" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Variation in Childhood Diarrheal Morbidity and Mortality in Africa, 2000-2015.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32513411" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Mapping geographical inequalities in childhood diarrhoeal morbidity and mortality in low-income and middle-income countries, 2000-17: analysis for the Global Burden of Disease Study 2017.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23680352" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27673470" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Use of quantitative molecular diagnostic methods to identify causes of diarrhoea in children: a reanalysis of the GEMS case-control study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37405406" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Azithromycin for bacterial watery diarrhea: A reanalysis of the AntiBiotics for Children with severe Diarrhea (ABCD) trial incorporating molecular diagnostics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27013692" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Norovirus Infection and Acquired Immunity in 8 Countries: Results From the MAL-ED Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34534487" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Association of enteropathogen detection with diarrhoea by age and high versus low child mortality settings: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28838152" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Etiology of Severe Acute Watery Diarrhea in Children in the Global Rotavirus Surveillance Network Using Quantitative Polymerase Chain Reaction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1659953" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Etiology of acute diarrhoea among children in developing countries: a multicentre study in five countries.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10516787" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Global burden of Shigella infections: implications for vaccine development and implementation of control strategies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11357989" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Mortality, morbidity, and microbiology of endemic cholera among hospitalized patients in Dhaka, Bangladesh.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9451670" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Diarrheal epidemics among Rwandan refugees in 1994. Management and outcome in a field hospital.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10371570" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Mortality in severely malnourished children with diarrhoea and use of a standardised management protocol.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3499247" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Causes of death in diarrhoeal diseases after rehydration therapy: an autopsy study of 140 patients in Bangladesh.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15794969" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : WHO estimates of the causes of death in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18752473" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Malnutrition as an enteric infectious disease with long-term effects on child development.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18382740" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Enteric infections, diarrhea, and their impact on function and development.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20016394" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Characteristics of children with Shigella encephalopathy: experience from a large urban diarrhea treatment center in Bangladesh.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28453565" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Risk factors and outcome of Shigella encephalopathy in Bangladeshi children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22492156" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Factors associated with encephalopathy in patients with Salmonella enterica serotype Typhi bacteremia presenting to a diarrheal hospital in Dhaka, Bangladesh.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19842390" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : High-dose intravenous dexamethasone in the management of diarrheal patients with enteric fever and encephalopathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9113963" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Validity and reliability of clinical signs in the diagnosis of dehydration in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8788288" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : How valid are clinical signs of dehydration in infants?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15187057" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Is this child dehydrated?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14627948" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Managing acute gastroenteritis among children: oral rehydration, maintenance, and nutritional therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14627948" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Managing acute gastroenteritis among children: oral rehydration, maintenance, and nutritional therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28953928" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Age specific fast breathing in under-five diarrheal children in an urban hospital: Acidosis or pneumonia?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19927041" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Clinical and laboratory features of radiologic pneumonia in severely malnourished infants attending an urban diarrhea treatment center in Bangladesh.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19772545" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Pneumonia in severely malnourished children in developing countries - mortality risk, aetiology and validity of WHO clinical signs: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19058611" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Predictors of severe illness in children under age five with concomitant infection with pneumonia and diarrhea at a large hospital in Dhaka, Bangladesh.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19058611" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Predictors of severe illness in children under age five with concomitant infection with pneumonia and diarrhea at a large hospital in Dhaka, Bangladesh.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16856044" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Oral versus intravenous rehydration for treating dehydration due to gastroenteritis in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34913980" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Effect of 3 Days of Oral Azithromycin on Young Children With Acute Diarrhea in Low-Resource Settings: A Randomized Clinical Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19821387" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Antibiotic therapy for Shigella dysentery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19821387" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Antibiotic therapy for Shigella dysentery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21735409" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Early versus Delayed Refeeding for Children with Acute Diarrhoea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27996088" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Oral zinc for treating diarrhoea in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18245424" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : A meta-analysis of the effects of oral zinc in the treatment of acute and persistent diarrhea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32966722" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Lower-Dose Zinc for Childhood Diarrhea - A Randomized, Multicenter Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17388664" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Loperamide therapy for acute diarrhea in children: systematic review and meta-analysis.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
